Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Firsthand Technology Value Fund Inc SVVC

Financial Services Asset Management
Firsthand Technology Value Fund, Inc. (the Fund) is a venture capital fund that invests in technology and cleantech companies. The Fund’s investment objective is to seek long-term growth of capital, principally by seeking capital gains on its equity and equity-related investments. Under normal circumstances, the Fund invests at least 80% of its net assets for investment purposes in technology... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCQB:SVVC)

Firsthand Technology Value Fund Announces Third Quarter Financial Results, NAV of $0.22 Per Share

GlobeNewswire 10 days ago

Firsthand Technology Value Fund Announces Second Quarter Financial Results, NAV of $0.15 Per Share

GlobeNewswire August 14, 2024

Firsthand Technology Value Fund Announces First Quarter Financial Results, NAV of $0.02 Per Share

GlobeNewswire May 14, 2024

Firsthand Technology Value Fund Announces Fiscal Year Financial Results, NAV of $0.18 Per Share

GlobeNewswire March 28, 2024

Firsthand Technology Value Fund Board Engages Ladenburg Thalmann & Co. Inc. to Explore Strategic Options to Increase Stockholder Value

Business Wire November 27, 2023

Firsthand Technology Value Fund Announces Third Quarter Financial Results, NAV of $0.10 Per Share

Business Wire November 14, 2023

Firsthand Technology Value Fund Announces Plan to Seek Stockholder Approval to Withdraw BDC Election and Pursue Liquidation

Business Wire October 13, 2023

Firsthand Technology Value Fund Announces Voluntary Delisting from Nasdaq Global Market

Business Wire October 6, 2023

Firsthand Technology Value Fund Announces Second Quarter Financial Results, NAV of $1.61 Per Share

Business Wire August 15, 2023
View More News ››

Opinion & Analysis (OTCQB:SVVC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCQB:SVVC)

Firsthand Technology Value Fund, Inc. (NASDAQ:SVVC): Navigat

http://beyondspx.com/2024/07/31/firsthand-technology-value-fund-inc-nasdaqsvvc-navigating-the-volatile-venture-capital-landscape/
MikeTester - August 2, 2024

Firsthand Technology Value Fund ($SVVC) - realizing value

Firsthand Technology Value Fund ($SVVC) - realizing value: http://buysidenotes.com/2014/05/02/firsthand-tech-fund-svvc-realizing-value/
buysidenotes - May 2, 2014

buysidenotes.com on SVVC

$SVVC and the hall of mirrors trade. http://buysidenotes.com/2014/03/17/firsthand-tech-fund-svvc-the-hall-of-mirrors-trade/
buysidenotes - March 17, 2014
View more Bullboard ››

Theralase Technologies Inc.

Theralase Technologies Inc.

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research ...
View More »